Advertisement
Screener

KEYSIGHT TECHNOLOGIES, INC. (KEYS) Spending and interest coverage

KEYSIGHT TECHNOLOGIES, INC. (KEYS) Spending and interest coverage

  • R&D / revenue · 12 months: Value 18.13%; Formula and calculation Research and development expense / revenue. Period ending 2026-07-31..
  • Stock-based compensation / revenue · 12 months: Value 3.25%; Formula and calculation Share-based compensation / revenue. Period ending 2026-07-31..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-07-31; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months18.13%Research and development expense / revenue. Period ending 2026-07-31.

$1.19B ÷ $6.58B × 100 ≈ 18.13%

Stock-based compensation / revenue · 12 months3.25%Share-based compensation / revenue. Period ending 2026-07-31.

$214.00M ÷ $6.58B × 100 ≈ 3.25%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending1.19B USDResearch and Development Expense
Revenue6.58B USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation214.00M USDShare-based Payment Arrangement, Noncash Expense
Operating income1.33B USDOperating Income (Loss)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-07-31$1.19B$6.58B$214.00M$1.33B(m)18.13%3.25%(m)(m)
2026-04-30$1.13B$6.09B$198.00M$1.11B(m)18.58%3.25%(m)(m)
2026-01-31$1.06B$5.68B$176.00M$906.00M(m)18.69%3.10%(m)(m)
2025-10-31$1.01B$5.38B$162.00M$876.00M$96.00M18.73%3.01%9.13×Reported
2025-07-31$982.00M$5.24B$155.00M$889.00M(m)18.73%2.96%(m)(m)
2025-04-30$958.00M$5.11B$153.00M$860.00M(m)18.75%3.00%(m)(m)
2025-01-31$936.00M$5.02B$151.00M$830.00M(m)18.65%3.01%(m)(m)
2024-10-31$919.00M$4.98B$137.00M$833.00M$84.00M18.46%2.75%9.92×Reported
2024-07-31$904.00M$5.00B$136.00M$920.00M(m)18.07%2.72%(m)(m)
2024-04-30$893.00M$5.17B$133.00M$1.08B(m)17.28%2.57%(m)(m)
2024-01-31$887.00M$5.34B$129.00M$1.26B$79.00M16.60%2.41%15.91×Reported
2023-10-31$882.00M$5.46B$135.00M$1.36B$78.00M16.14%2.47%17.41×Reported
2023-07-31$879.00M$5.60B$133.00M$1.42B$78.00M15.71%2.38%18.21×Reported
2023-04-30$870.00M$5.59B$132.00M$1.41B$79.00M15.56%2.36%17.87×Reported
2023-01-31$858.00M$5.55B$129.00M$1.39B$78.00M15.46%2.32%17.76×Reported
2022-10-31$841.00M$5.42B$125.00M$1.33B$79.00M15.52%2.31%16.89×Reported
2022-07-31$822.00M$5.27B$122.00M$1.30B$79.00M15.59%2.31%16.51×Reported
2022-04-30$823.00M$5.14B$116.00M$1.23B$79.00M16.01%2.26%15.58×Reported
2022-01-31$822.00M$5.01B$110.00M$1.14B$79.00M16.40%2.20%14.42×Reported
2021-10-31$811.00M$4.94B$103.00M$1.08B$79.00M16.41%2.08%13.67×Reported
2021-07-31$808.00M$4.87B$103.00M$1.01B$78.00M16.60%2.12%12.94×Reported
2021-04-30$770.00M$4.63B$102.00M$907.00M$78.00M16.62%2.20%11.63×Reported
2021-01-31$727.00M$4.31B$96.00M$774.00M$79.00M16.88%2.23%9.80×Reported
2020-10-31$715.00M$4.22B$92.00M$765.00M$78.00M16.94%2.18%9.81×Reported
2020-07-31$698.00M$4.12B$88.00M$695.00M$79.00M16.94%2.14%8.80×Reported
2020-04-30$697.00M$4.20B$86.00M$710.00M$79.00M16.61%2.05%8.99×Reported
2020-01-31$702.00M$4.39B$94.00M$793.00M$79.00M15.98%2.14%10.04×Reported
2019-10-31$688.00M$4.30B$82.00M$711.00M$80.00M15.99%1.91%8.89×Reported
2019-07-31$672.00M(m)$77.00M$-77.00M$80.00M(m)(m)-0.96×Reported
2019-04-30$641.00M(m)$75.00M$-109.00M$80.00M(m)(m)-1.36×Reported
2019-01-31$630.00M(m)$67.00M$-208.00M$81.00M(m)(m)-2.57×Reported
2018-10-31$607.00M(m)$59.00M$-346.00M$83.00M(m)(m)-4.17×Reported
2018-07-31$592.00M(m)$60.00M$262.00M$85.00M(m)(m)3.08×Reported
2018-04-30$573.00M(m)$59.00M$130.00M$87.00M(m)(m)1.49×Reported
2018-01-31$536.00M(m)$57.00M$72.00M$90.00M(m)(m)0.80×Reported
2017-10-31$498.00M$3.19B$56.00M$239.00M$80.00M15.62%1.76%2.99×Reported
2017-07-31$464.00M(m)$54.00M$307.00M$70.00M(m)(m)4.39×Reported
2017-04-30$436.00M(m)$51.00M$417.00M$59.00M(m)(m)7.07×Reported
2017-01-31$425.00M(m)$51.00M$470.00M$47.00M(m)(m)10.00×Reported
2016-10-31$425.00M$2.92B$49.00M$406.00M$47.00M14.56%1.68%8.64×Reported
2016-07-31$425.00M$2.92B$45.00M$410.00M$46.00M14.57%1.54%8.91×Reported
2016-04-30$411.00M$2.87B$42.00M$404.00M$47.00M14.34%1.46%8.60×Reported
2016-01-31$399.00M$2.88B$42.00M$442.00M$46.00M13.87%1.46%9.61×Reported
2015-10-31$387.00M$2.86B$55.00M$431.00M$46.00M13.55%1.93%9.37×Reported
2015-07-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2015-04-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2015-01-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-10-31$361.00M$2.93B$43.00M$469.00M$3.00M12.31%1.47%156.33×Reported
2014-07-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-04-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-01-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-10-31$375.00M$2.89B$41.00M$496.00M$0.0012.98%1.42%(m)Reported

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
AMETEK INC/ (AME)United States$56.772B35.17
ROPER TECHNOLOGIES INC (ROP)United States$36.012B13.63
MKS INC (MKSI)United States$17.440B68.37
Fortive Corp (FTV)United States$16.897B31.51
COGNEX CORP (CGNX)United States$9.711B65.26
Ralliant Corp (RAL)United States$7.737B-6.14
Sensata Technologies Holding plc (ST)$5.976B77.15
MESA LABORATORIES INC /CO/ (MLAB)United States$0.768B116.22
Senseonics Holdings, Inc. (SENS)United States$0.546B-2.74
HURCO COMPANIES INC (HURC)United States$0.140B-20.39